Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 5, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 14, 2026
10% ownerIndirect holdingGrant / award
Context
Classification
grant award
Derivative acquisition at no reported price
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213900-26-109486
Filed / recorded
Oct 14, 2026, 9:30 PM UTC
Added to OQRO
Oct 14, 2026, 9:35 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
authID Inc.
Issuer CIK
1534154
Ticker
AUID
Reporting person
Garchik Stephen Jeffrey
Relationship
10% owner
Security
Stock Purchase Warrant
Table
Derivative (Table II)
Transaction date
Oct 5, 2026
Transaction code
J
Shares / units
1,000,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,000,000
Ownership form
Indirect — See Footnotes
Amendment
No
Footnotes from the filing
On April 29, 2026, the Trust acquired a Stock Purchase Warrant to purchase 1,000,000 shares of Common Stock at $1.50 per share, exercisable beginning October 29, 2026 and expiring April 29, 2031 (the "April Warrant"). Effective September 15, 2026, pursuant to the amendments described in footnote (5), the exercise price was reduced to $0.57 per share. Effective October 5, 2026, pursuant to the October Consent, it was further reduced to $0.50 per share in consideration of the holders' agreement to extend the maturity of the April 2026 Senior Secured Debentures and consent to the Issuer's October 2026 financing. No other term was changed, and the Trust paid no cash for either reduction. Each reduction is reported, as of its effective date, as a disposition of the April Warrant at its prior exercise price and the acquisition of a warrant at the reduced price, with no change in underlying shares, exercisability or expiration. Exercise is subject to the limitations in footnote (11).
Stephen J. Garchik ("Mr. Garchik") disclaims beneficial ownership of any and all of the Issuer's securities reported herein in excess of his actual pecuniary interest.
Held by the Marla Garchik Irrevocable 2020 Trust (the "Trust") of which Mr. Garchik is a beneficiary.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.